- Home
- COLL vs HOPE Comparison
COLL vs HOPE Comparison
Compare COLL & HOPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COLL | HOPE |
|---|---|---|
| Founded | 2002 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | COLL | HOPE |
|---|---|---|
| Price | $47.02 | $10.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $47.50 | $13.25 |
| AVG Volume (30 Days) | 550.1K | ★ 862.8K |
| Earning Date | 11-06-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 5.12% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.63 | 0.39 |
| Revenue | ★ $757,067,000.00 | $431,631,000.00 |
| Revenue This Year | $26.35 | $19.31 |
| Revenue Next Year | $3.67 | $12.90 |
| P/E Ratio | $29.21 | ★ $28.31 |
| Revenue Growth | ★ 26.34 | N/A |
| 52 Week Low | $23.23 | $8.83 |
| 52 Week High | $49.09 | $13.67 |
Technical Indicators
Market Signals| Indicator | COLL | HOPE |
|---|---|---|
| Relative Strength Index (RSI) | 68.88 | 60.55 |
| Support Level | $46.81 | $10.53 |
| Resistance Level | $49.09 | $10.99 |
| Average True Range (ATR) | 1.33 | 0.25 |
| MACD | -0.19 | 0.08 |
| Stochastic Oscillator | 69.59 | 81.07 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About HOPE Hope Bancorp Inc.
Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services and other banking services.